Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3442)
All Articles published online
|
May 28, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ormandy LA, Färber A, Cantz T, Petrykowska S, Wedemeyer H, Hörning M, Lehner F, Manns MP, Korangy F, Greten TF. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(20): 3275-3282 [PMID: 16718852 DOI: 10.3748/wjg.v12.i20.3275] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i20/3275.htm |
| Number | Citing Articles |
| 1 |
Ekaterina Breous, Robert Thimme. Potential of immunotherapy for hepatocellular carcinoma. Journal of Hepatology 2011; 54(4): 830 doi: 10.1016/j.jhep.2010.10.013
|
| 2 |
Jingnan Xu, Zhuo Song, Qiujun Guo, Jie Li. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/1490738
|
| 3 |
Fang Zhao, Christine Falk, Wolfram Osen, Masashi Kato, Dirk Schadendorf, Viktor Umansky. Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic inRetTransgenic Mice Spontaneously Developing Melanoma. Clinical Cancer Research 2009; 15(13): 4382 doi: 10.1158/1078-0432.CCR-09-0399
|
| 4 |
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20): 33897 doi: 10.18632/oncotarget.15406
|
| 5 |
Kyle K Payne, Hussein F Aqbi, Savannah E Butler, Laura Graham, Rebecca C Keim, Wen Wan, Michael O Idowu, Harry D Bear, Xiang-Yang Wang, Masoud H Manjili. Gr1−/lowCD11b−/lowMHCII+ myeloid cells boost T cell anti-tumor efficacy. Journal of Leukocyte Biology 2018; 104(6): 1215 doi: 10.1002/JLB.5A0717-276RR
|
| 6 |
Dmitry I. Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo Bronte. Coordinated regulation of myeloid cells by tumours. Nature Reviews Immunology 2012; 12(4): 253 doi: 10.1038/nri3175
|
| 7 |
Annalisa Legitimo, Rita Consolini, Alessandra Failli, Giulia Orsini, Roberto Spisni. Dendritic cell defects in the colorectal cancer. Human Vaccines & Immunotherapeutics 2014; 10(11): 3224 doi: 10.4161/hv.29857
|
| 8 |
Benjamin Ruf, Bernd Heinrich, Tim F. Greten. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cellular & Molecular Immunology 2021; 18(1): 112 doi: 10.1038/s41423-020-00572-w
|
| 9 |
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease. International Journal of Molecular Sciences 2013; 14(11): 22022 doi: 10.3390/ijms141122022
|
| 10 |
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(17): 4387 doi: 10.3390/cancers13174387
|
| 11 |
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15): 5250 doi: 10.3390/ijms21155250
|
| 12 |
Charlotte Rennert, Julia Lang‐Meli, Mikhail Gromak, Maike Hofmann, Robert Thimme, Natascha Roehlen. Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment. Liver Cancer International 2023; 4(1): 42 doi: 10.1002/lci2.70
|
| 13 |
Eunjeong Kim. Tumor Immune Microenvironment as a New Therapeutic Target for
Hepatocellular Carcinoma Development. Development & Reproduction 2023; 27(4): 167 doi: 10.12717/DR.2023.27.4.167
|
| 14 |
Suresh Kalathil, Amit A. Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala. Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality. Cancer Research 2013; 73(8): 2435 doi: 10.1158/0008-5472.CAN-12-3381
|
| 15 |
Jana C Mossanen, Frank Tacke. Role of lymphocytes in liver cancer. OncoImmunology 2013; 2(11): e26468 doi: 10.4161/onci.26468
|
| 16 |
Silvia Martin Lluesma, Michele Graciotti, Cheryl Chiang, Lana Kandalaft. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?. Vaccines 2018; 6(4): 79 doi: 10.3390/vaccines6040079
|
| 17 |
Angela D. Pardee, Jian Shi, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells. The Journal of Immunology 2014; 193(11): 5723 doi: 10.4049/jimmunol.1400725
|
| 18 |
Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon, Qi Zhang. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World Journal of Hepatology 2015; 7(7): 980-992 doi: 10.4254/wjh.v7.i7.980
|
| 19 |
Viktor Umansky, Dirk Schadendorf. Dendritic Cells in Cancer. 2009; : 89 doi: 10.1007/978-0-387-88611-4_6
|
| 20 |
Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin, Michael R. Shurin. Tumor associated regulatory dendritic cells. Seminars in Cancer Biology 2012; 22(4): 298 doi: 10.1016/j.semcancer.2012.02.010
|
| 21 |
Jyh-Chiang E. Wang, James J. Kobie, Li Zhang, Matthew Cochran, Tim R. Mosmann, Christopher T. Ritchlin, Sally A. Quataert. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. Journal of Immunological Methods 2009; 341(1-2): 106 doi: 10.1016/j.jim.2008.11.002
|
| 22 |
Tobias Flecken, Hans Christian Spangenberg, Robert Thimme. Immunobiology of hepatocellular carcinoma. Langenbeck's Archives of Surgery 2012; 397(5): 673 doi: 10.1007/s00423-011-0783-x
|
| 23 |
Differential ratios of fish/corn oil ameliorated the colon carcinoma in rat by altering intestinal intraepithelial CD8+ T lymphocytes, dendritic cells population and modulating the intracellular cytokines. Biomedicine & Pharmacotherapy 2018; 98: 600 doi: 10.1016/j.biopha.2017.12.041
|
| 24 |
Michael R. Shurin, Anton A. Keskinov. Encyclopedia of Immunobiology. 2016; : 499 doi: 10.1016/B978-0-12-374279-7.17014-6
|
| 25 |
Vasily Kurilin, Alina Alshevskaya, Sergey Sennikov. Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases. Biomedicines 2024; 12(3): 699 doi: 10.3390/biomedicines12030699
|
| 26 |
Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W. Beury, Virginia K. Clements. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Seminars in Cancer Biology 2012; 22(4): 275 doi: 10.1016/j.semcancer.2012.01.011
|
| 27 |
Tobias Flecken, Robert Thimme. Hepatocellular Carcinoma. 2016; : 199 doi: 10.1007/978-3-319-34214-6_13
|
| 28 |
Stefania Mantovani, Barbara Oliviero, Andrea Lombardi, Stefania Varchetta, Dalila Mele, Angelo Sangiovanni, Giorgio Rossi, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Camillo Porta, Paolo Pedrazzoli, Silvia Chiellino, Roberto Santambrogio, Enrico Opocher, Marcello Maestri, Stefano Bernuzzi, Armando Rossello, Sophie Clément, Claudio De Vito, Laura Rubbia‐Brandt, Francesco Negro, Mario U. Mondelli. Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma. Hepatology 2019; 69(3): 1165 doi: 10.1002/hep.30235
|
| 29 |
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of Disease. Pathology & Oncology Research 2014; 20(2): 267 doi: 10.1007/s12253-013-9691-4
|
| 30 |
Seo-Young Koo, Eun-Ji Park, Chang-Woo Lee. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Experimental & Molecular Medicine 2020; 52(8): 1209 doi: 10.1038/s12276-020-0480-3
|
| 31 |
Xiaopei Hao, Guangshun Sun, Yao Zhang, Xiangyi Kong, Dawei Rong, Jinhua Song, Weiwei Tang, Xuehao Wang. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.775462
|
| 32 |
Zhengkun Tu, Heli K. Hamalainen-Laanaya, Chiaki Nishitani, Yoshio Kuroki, Ian Nicholas Crispe, Mark S. Orloff. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. International Immunology 2012; 24(2): 97 doi: 10.1093/intimm/dxr104
|
| 33 |
Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.724883
|
| 34 |
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Gennaro Ciliberto, Franco M Buonaguro, Luigi Buonaguro. Combinatorial immunotherapy strategies for hepatocellular carcinoma. Current Opinion in Immunology 2016; 39: 103 doi: 10.1016/j.coi.2016.01.005
|
| 35 |
Yuri Cho, Jimin Han, Won Kim. Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1): 1 doi: 10.17998/jlc.19.1.1
|
| 36 |
Sneha Mathew, Kristy L. Bauer, Arne Fischoeder, Nina Bhardwaj, Stephen J. Oliver. The Anergic State in Sarcoidosis Is Associated with Diminished Dendritic Cell Function. The Journal of Immunology 2008; 181(1): 746 doi: 10.4049/jimmunol.181.1.746
|
| 37 |
Yutong Chen, Weiran Huang, Jian Ouyang, Jingxiang Wang, Zhengwei Xie. Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(3): 2862 doi: 10.3390/ijms24032862
|
| 38 |
Rachel Grossman, Zvi Ram. Monocyte-Derived Cells of the Brain in Malignant Gliomas. World Neurosurgery 2014; 82(6): 1012 doi: 10.1016/j.wneu.2013.01.074
|
| 39 |
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Jens Werner, Svetlana Karakhanova. Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02129
|
| 40 |
Federico Costante, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. World Journal of Gastrointestinal Oncology 2022; 14(9): 1622-1636 doi: 10.4251/wjgo.v14.i9.1622
|
| 41 |
Denise A. Caruso, Sarah Fraser, Kellie Hardy, Gerlinda Amor, Jorinde J. Helmich, David M. Ashley. Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. Experimental Hematology 2008; 36(12): 1691 doi: 10.1016/j.exphem.2008.07.003
|
| 42 |
Alexandre Harari, Michele Graciotti, Michal Bassani-Sternberg, Lana E. Kandalaft. Antitumour dendritic cell vaccination in a priming and boosting approach. Nature Reviews Drug Discovery 2020; 19(9): 635 doi: 10.1038/s41573-020-0074-8
|
| 43 |
Junfei Jin, Pengpeng Zhu, Yan Liao, Jun Li, Weijia Liao, Songqing He. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection. Oncotarget 2015; 6(22): 19217 doi: 10.18632/oncotarget.4265
|
| 44 |
XINLI HUANG, JIANJIE QIN, SEN LU. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation-induced tumor growth. Molecular Medicine Reports 2014; 10(4): 2153 doi: 10.3892/mmr.2014.2479
|
| 45 |
|
| 46 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1): 437 doi: 10.3390/ijms24010437
|
| 47 |
|
| 48 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2006; 45(6): 868 doi: 10.1016/j.jhep.2006.09.004
|
| 49 |
Michael R. Shurin, Gurkamal S. Chatta. Tumor-Induced Immune Suppression. 2008; : 101 doi: 10.1007/978-0-387-69118-3_6
|
| 50 |
S M Wörmann, K N Diakopoulos, M Lesina, H Algül. The immune network in pancreatic cancer development and progression. Oncogene 2014; 33(23): 2956 doi: 10.1038/onc.2013.257
|
| 51 |
Izabela Łapuć, Andrzej Eljaszewicz, Janusz Kłoczko, Marcin Moniuszko. Rola monocytów w patogenezie przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 2014; 45(4): 340 doi: 10.1016/j.achaem.2014.06.001
|
| 52 |
Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs‐Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt‐Wolf, Maria A. Gonzalez‐Carmona. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivo. Liver International 2014; 34(3): 447 doi: 10.1111/liv.12284
|
| 53 |
Michael R. Shurin, Anton A. Keskinov, Gurkamal S. Chatta. Tumor-Induced Immune Suppression. 2014; : 151 doi: 10.1007/978-1-4899-8056-4_5
|
| 54 |
Angela D. Pardee, Lisa H. Butterfield. Immunotherapy of hepatocellular carcinoma. OncoImmunology 2012; 1(1): 48 doi: 10.4161/onci.1.1.18344
|
| 55 |
Han Huang, Jiansong Fang, Xiude Fan, Tatsunori Miyata, Xiaoyue Hu, Lihe Zhang, Liangren Zhang, Yimin Cui, Zhenming Liu, Xiaoqin Wu. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01009
|
| 56 |
Patricia M. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells. Cancer Immunology Research 2019; 7(6): 1001 doi: 10.1158/2326-6066.CIR-18-0513
|
| 57 |
Bastian Hoechst, Lars A. Ormandy, Matthias Ballmaier, Frank Lehner, Christine Krüger, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells. Gastroenterology 2008; 135(1): 234 doi: 10.1053/j.gastro.2008.03.020
|
| 58 |
Kohei Shigeta, Tai Hato, Yunching Chen, Dan G. Duda. Immunotherapy of Hepatocellular Carcinoma. 2017; : 85 doi: 10.1007/978-3-319-64958-0_6
|
| 59 |
Jianting Long, Bo Zhou, Heping Li, Qiangsheng Dai, Bing Zhang, Sizhong Xing, Zhirong Zeng, Wei Chen, Jianyong Yang. Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide. Immunological Investigations 2013; 42(2): 137 doi: 10.3109/08820139.2012.744418
|
| 60 |
Guangwen Shu, Tianming Yang, Chaoyuan Wang, Hanwen Su, Meixian Xiang. Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cells. Toxicology and Applied Pharmacology 2013; 269(3): 270 doi: 10.1016/j.taap.2013.02.019
|
| 61 |
YeunHwa Gu, Yoshiaki Fujimiya, Yuka Itokawa, Masami Oshima, Jung-Sook Choi, Toshihiro Miura, Torao Ishida. Tumoricidal Effects of β-Glucans: Mechanisms Include Both Antioxidant Activity Plus Enhanced Systemic and Topical Immunity. Nutrition and Cancer 2008; 60(5): 685 doi: 10.1080/01635580802030884
|
| 62 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Myeloid derived suppressor cells in human diseases. International Immunopharmacology 2011; 11(7): 802 doi: 10.1016/j.intimp.2011.01.003
|
| 63 |
Minoru Kobayashi, Taro Kubo, Kenji Komatsu, Akira Fujisaki, Fumihito Terauchi, Shinsuke Natsui, Akinori Nukui, Shinsuke Kurokawa, Tatsuo Morita. Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0556-1
|
| 64 |
Audry Fernández, Amaury Pupo, Karel Mena-Ulecia, Carlos Gonzalez. Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives. Molecular Pharmacology 2016; 90(3): 385 doi: 10.1124/mol.116.103804
|
| 65 |
James Yu, Vadim Zaytsev, Aimen Farooq, Anum Jalil, James Wert, Zohaib Ahmed, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 245 doi: 10.1016/B978-0-323-99283-1.00022-7
|
| 66 |
Maria A. Gonzalez‐Carmona, Veronika Lukacs‐Kornek, Anne Timmerman, Sara Shabani, Miroslaw Kornek, Annabelle Vogt, Yildiz Yildiz, Elisabeth Sievers, Ingo G.H. Schmidt‐Wolf, Wolfgang H. Caselmann, Tilman Sauerbruch, Volker Schmitz. CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo. Hepatology 2008; 48(1): 157 doi: 10.1002/hep.22296
|
| 67 |
Xiaoqin Zheng, Wenjie Jin, Shanshan Wang, Huiguo Ding. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.729705
|
| 68 |
Tim F. Greten, Firouzeh Korangy. Clinical Dilemmas in Primary Liver Cancer. 2011; : 191 doi: 10.1002/9781119962205.ch27
|
| 69 |
Tong Liu, Zhuhui Yuan, Hao Wang, Junjie Wang, Lixiang Xue. Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 101835 doi: 10.1016/j.clinre.2021.101835
|
| 70 |
Kouichi Momiyama, Hidenari Nagai, Yasukiyo Sumino. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy. Cancer Chemotherapy and Pharmacology 2009; 64(2): 271 doi: 10.1007/s00280-008-0866-8
|
| 71 |
Firouzeh Korangy, Bastian Höchst, Michael P Manns, Tim F Greten. Immunotherapy of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2010; 4(3): 345 doi: 10.1586/egh.10.18
|
| 72 |
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009; 50(3): 799 doi: 10.1002/hep.23054
|
| 73 |
Antonio Saviano, Natascha Roehlen, Alessia Virzì, Armando Andres Roca Suarez, Yujin Hoshida, Joachim Lupberger, Thomas F. Baumert. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 317 doi: 10.1007/978-3-030-21540-8_15
|
| 74 |
Sonja Obermann, Susanne Petrykowska, Michael P. Manns, Firouzeh Korangy, Tim F. Greten. Peptide‐β2‐microglobulin‐major histocompatibility complex expressing cells are potent antigen‐presenting cells that can generate specific T cells. Immunology 2007; 122(1): 90 doi: 10.1111/j.1365-2567.2007.02616.x
|